JCR Pharmaceuticals Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	3,224	-6,414	7,244	5,412	19,404
Depreciation & Amortization	2,557	3,374	3,197	1,997	1,945
Loss (Gain) From Sale of Investments	-667	-	-	-	-
Loss (Gain) on Equity Investments	184	467	1,090	-	-
Other Operating Activities	750	-2,276	1,982	-8,280	-2,520
Change in Accounts Receivable	-1,927	2,698	-3,797	4,448	-7,402
Change in Inventory	-1,853	-822	-2,437	-3,877	-1,082
Change in Accounts Payable	290	-2,003	1,854	-2,892	1,305
Change in Other Net Operating Assets	-2,693	-510	179	-2,308	-2,361
Operating Cash Flow	-135	-5,486	9,312	-5,500	9,289
Operating Cash Flow Growth	-	-	-	-	-10.17%
Capital Expenditures	-11,427	-9,888	-1,526	-7,654	-11,333
Cash Acquisitions	-	-	-600	-6,717	-
Divestitures	-	145	-	-	-
Sale (Purchase) of Intangibles	-154	-	-569	-906	-
Investment in Securities	1,670	-	-	259	-
Other Investing Activities	-2,593	-131	5	16	8,083
Investing Cash Flow	-12,504	-9,874	-2,690	-15,002	-3,250
Short-Term Debt Issued	15,087	14,805	-	3,000	-
Long-Term Debt Issued	3,750	750	9,600	4,750	750
Total Debt Issued	18,837	15,555	9,600	7,750	750
Short-Term Debt Repaid	-	-	-6,900	-	-
Long-Term Debt Repaid	-3,050	-750	-2,200	-3,050	-750
Total Debt Repaid	-3,050	-750	-9,100	-3,050	-750
Net Debt Issued (Repaid)	15,787	14,805	500	4,700	-
Issuance of Common Stock	8	21	-	-	-
Repurchase of Common Stock	-	-2,530	15	10	10
Common Dividends Paid	-2,441	-2,505	-2,500	-2,739	-2,169
Other Financing Activities	-49	-55	-46	-23	-20
Financing Cash Flow	13,305	9,736	-2,031	1,948	-2,179
Foreign Exchange Rate Adjustments	145	64	886	1,099	612
Miscellaneous Cash Flow Adjustments	-	1	-	1	-
Net Cash Flow	811	-5,559	5,477	-17,454	4,472
Free Cash Flow	-11,562	-15,374	7,786	-13,154	-2,044
Free Cash Flow Margin	-28.68%	-46.49%	18.16%	-38.30%	-4.00%
Free Cash Flow Per Share	-94.81	-124.16	62.09	-105.37	-16.46
Cash Interest Paid	413	147	87	46	45
Cash Income Tax Paid	-763	2,284	-1,982	8,279	2,517
Levered Free Cash Flow	-24,702	-13,174	4,178	-15,235	4,843
Unlevered Free Cash Flow	-24,454	-13,077	4,232	-15,207	4,871
Change in Working Capital	-6,183	-637	-4,201	-4,629	-9,540

Source: S&P Global Market Intelligence. Standard template. Financial Sources.